# OnCo record personalis (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/personalis/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "personalis" ;
  schema:name "Personalis (Tempus)"@en ;
  schema:description "Maker of the ultra-sensitive NeXT Personal MRD test, being acquired by Tempus AI for about $1.5B (announced July 2026)."@en ;
  schema:url <https://onco.cc/companies/personalis/>, <https://www.personalis.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://investors.tempus.com/news-releases/news-release-details/tempus-acquire-personalis-more-tightly-integrating-molecular> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/wes-wgs/>, <https://onco.cc/technologies/cgp/> ;
  onco:companies <https://onco.cc/companies/tempus/> ;
  onco:terms <https://onco.cc/terms/mrd/> .
